Form D · Biotechnology
CapeHaven Holding Company, LLC
New Haven, CT · CIK 0002078271
Offering snapshot reported Jul 24, 2025 · SEC filing
- Reported sold
- $1.43M Offering amount: $4.95M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 11, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 24, 2025 | Initial | $1,430,000 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-552740
Source: Form D, filed Jul 24, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ranjit Bindra | Director |
| Michael Dillon | Director |
| Kevin L. Rakin | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
55 Church Street
New Haven, CT, 06510
New Haven, CT, 06510